VEGF signaling: Role in angiogenesis and beyond

P Shaw, SKD Dwivedi, R Bhattacharya… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Angiogenesis is a crucial process for tissue development, repair, and tumor survival.
Vascular endothelial growth factor (VEGF) is a key driver secreted by cancer cells …

Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?

R Fasano, S Serratì, T Rafaschieri, V Longo, R Di Fonte… - Biomolecules, 2024 - mdpi.com
Small-cell lung cancer (SCLC) cases represent approximately 15% of all lung cancer cases,
remaining a recalcitrant malignancy with poor survival and few treatment options. In the last …

Extracellular lactic acidosis of the tumor microenvironment drives adipocyte-to-myofibroblast transition fueling the generation of cancer-associated fibroblasts

E Andreucci, BS Fioretto, I Rosa, M Matucci-Cerinic… - Cells, 2023 - mdpi.com
Lactic acidosis characterizes the tumor microenvironment (TME) and is involved in the
mechanisms leading to cancer progression and dissemination through the reprogramming …

Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma

W Yang, Z Li, W Wang, J Wu, J Li, X Huang… - Frontiers in …, 2023 - frontiersin.org
Background: Lung cancer has a high incidence and mortality rate worldwide. Vasculogenic
mimicry (VM) is a specific modality of tumor angiogenesis that could potentially be a new …

Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors …

T Ceruti, R Frapolli, C Ghilardi, A Decio, G Dellavedova… - Molecules, 2023 - mdpi.com
We describe the development and validation of an HPLC-MS/MS method to assess the
pharmacokinetics and tumour distribution of ZST316, an arginine analogue with inhibitory …

VE-Cadherin in cancer-associated angiogenesis: A deceptive strategy of blood vessel formation

D Delgado-Bellido, FJ Oliver… - International Journal of …, 2023 - mdpi.com
Tumor growth depends on the vascular system, either through the expansion of blood
vessels or novel adaptation by tumor cells. One of these novel pathways is vasculogenic …

Deciphering the sequential changes of monocytes/macrophages in the progression of IDD with longitudinal approach using single-cell transcriptome

W Li, Y Zhao, Y Wang, Z He, L Zhang, B Yuan… - Frontiers in …, 2023 - frontiersin.org
Intervertebral disk degeneration (IDD) is a chronic inflammatory disease with intricate
connections between immune infiltration and oxidative stress (OS). Complex cell niches …

Functional roles of microRNAs in vasculogenic mimicry and resistance to therapy in human cancers: an update

AP García-Hernández… - Expert Review of …, 2024 - Taylor & Francis
Introduction Vasculogenic mimicry (VM) alludes to the ability of cancer cells to organize on
three-dimensional channel-like structures to obtain nutrients and oxygen. This mechanism …

COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma

J Chen, SY Dai, S Wu, MK Wu, KK Yu, JC Liu… - Frontiers in …, 2024 - frontiersin.org
Background Vasculogenic Mimicry (VM) can reduce the efficacy of anti-angiogenesis and
promote distant metastasis in hepatocellular carcinoma (HCC). Our previous studies have …

[PDF][PDF] The role of mesenchymal stem cell-derived exosomes in tumor progression.

CR HARREL, V DJONOV, ANA VOLAREVIC… - Biocell, 2023 - cdn.techscience.cn
Exosomes derived from mesenchymal stem cells (MSC-Exos) are nano-sized extracellular
vesicles enriched with bioactive molecules, such as microRNAs, enzymes, cytokines …